ReviewClinical neuroradiology2026
Granulomatous Diseases of the CNS: Aetiology, Neuroradiological Features and Clinical Findings.
Review in Clinical neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatous disorders of the central nervous system (CNS) encompass a highly heterogeneous group of diseases with autoinflammatory, autoimmune, infectious, proliferative-neoplastic, foreign body-related, or drug-induced aetiologies. Neuroimaging plays a pivotal role, particularly with respect to early diagnosis. Therefore, knowledge of specific imaging patterns is crucial in order to narrow down the broad differential diagnosis. Although imaging cannot replace histology, its importance in initiating therapy as early as possible is indisputable. This is particularly true since many granulomatous diseases respond to treatment, usually with immunosuppressants and/or anti-infectives. This review highlights representative disease entities across the major aetiological categories and discusses key neuroradiological features and clinical symptoms together with relevant differential diagnostic considerations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.